CytoSorbents Corp. (CTSO)
0.64
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 14:02
CytoSorbents Cash from Investing (Quarterly) : 0.055M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.466M |
| Quest Diagnostics, Inc. | -191.00M |
| Danaher Corp. | -384.00M |
| Cardiac Biotech Solutions, Inc. | -- |
| Odyssey Health, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.577M |
| Free Cash Flow | -10.14M |
| Free Cash Flow Per Share (Quarterly) | -0.0402 |
| Free Cash Flow to Equity (Quarterly) | -2.596M |
| Free Cash Flow to Firm (Quarterly) | -1.949M |
| Free Cash Flow Yield | -25.83% |